Ameritas Investment Partners’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $131K | Hold |
15,419
| – | – | ﹤0.01% | 1526 |
|
|
2025
Q4 | $187K | Buy |
15,419
+3,675
| +31% | +$44.6K | 0.01% | 1292 |
|
|
2025
Q3 | $137K | Sell |
11,744
-2,608
| -18% | -$31.2K | ﹤0.01% | 1486 |
|
|
2025
Q2 | $133K | Sell |
14,352
-893
| -6% | -$6.99K | ﹤0.01% | 1560 |
|
|
2025
Q1 | $112K | Hold |
15,245
| – | – | ﹤0.01% | 1628 |
|
|
2024
Q4 | $130K | Hold |
15,245
| – | – | ﹤0.01% | 1607 |
|
|
2024
Q3 | $133K | Hold |
15,245
| – | – | ﹤0.01% | 1609 |
|
|
2024
Q2 | $104K | Buy |
15,245
+3,714
| +32% | +$22.9K | ﹤0.01% | 1696 |
|
|
2024
Q1 | $105K | Buy |
11,531
+3,257
| +39% | +$23.1K | ﹤0.01% | 1705 |
|
|
2023
Q4 | $36.9K | Buy |
8,274
+2,529
| +44% | +$7.48K | ﹤0.01% | 2315 |
|
|
2023
Q3 | $18K | Hold |
5,745
| – | – | ﹤0.01% | 2589 |
|
|
2023
Q2 | $29.6K | Hold |
5,745
| – | – | ﹤0.01% | 2338 |
|
|
2023
Q1 | $30.3K | Hold |
5,745
| – | – | ﹤0.01% | 2263 |
|
|
2022
Q4 | $22.4K | Hold |
5,745
| – | – | ﹤0.01% | 2515 |
|
|
2022
Q3 | $23K | Hold |
5,745
| – | – | ﹤0.01% | 2456 |
|
|
2022
Q2 | $23K | Hold |
5,745
| – | – | ﹤0.01% | 2489 |
|
|
2022
Q1 | $28K | Hold |
5,745
| – | – | ﹤0.01% | 2402 |
|
|
2021
Q4 | $40K | Hold |
5,745
| – | – | ﹤0.01% | 2276 |
|
|
2021
Q3 | $57K | Hold |
5,745
| – | – | ﹤0.01% | 2068 |
|
|
2021
Q2 | $81K | Hold |
5,745
| – | – | ﹤0.01% | 1865 |
|
|
2021
Q1 | $94K | Hold |
5,745
| – | – | ﹤0.01% | 1714 |
|
|
2020
Q4 | $119K | Buy |
5,745
+1,216
| +27% | +$18.1K | 0.01% | 1475 |
|
|
2020
Q3 | $34K | Hold |
4,529
| – | – | ﹤0.01% | 2079 |
|
|
2020
Q2 | $38K | Buy |
4,529
+900
| +25% | +$5.96K | ﹤0.01% | 1997 |
|
|
2020
Q1 | $18K | Buy |
3,629
+1,650
| +83% | +$8.15K | ﹤0.01% | 2240 |
|
|
2019
Q4 | $8K | Hold |
1,979
| – | – | ﹤0.01% | 2805 |
|
|
2019
Q3 | $6K | Hold |
1,979
| – | – | ﹤0.01% | 2899 |
|
|
2019
Q2 | $9K | Hold |
1,979
| – | – | ﹤0.01% | 2830 |
|
|
2019
Q1 | $8K | Hold |
1,979
| – | – | ﹤0.01% | 2768 |
|
|
2018
Q4 | $8K | Hold |
1,979
| – | – | ﹤0.01% | 2743 |
|
|
2018
Q3 | $14K | Hold |
1,979
| – | – | ﹤0.01% | 2695 |
|
|
2018
Q2 | $13K | Hold |
1,979
| – | – | ﹤0.01% | 2736 |
|
|
2018
Q1 | $13K | Hold |
1,979
| – | – | ﹤0.01% | 2632 |
|
|
2017
Q4 | $9K | Hold |
1,979
| – | – | ﹤0.01% | 2780 |
|
|
2017
Q3 | $12K | Hold |
1,979
| – | – | ﹤0.01% | 2704 |
|
|
2017
Q2 | $18K | Buy |
1,979
+973
| +97% | +$9.42K | ﹤0.01% | 2523 |
|
|
2017
Q1 | $9K | Buy |
+1,006
| New | +$8.38K | ﹤0.01% | 2731 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
Ameritas Investment Partners's OCUL Position: Q1 2026 in Review
Ameritas Investment Partners held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 15,419 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.
Ameritas Investment Partners first reported a position in OCUL in Q1 2017 and has held it in 37 quarters since. The position peaked at $187K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.
- Ameritas Investment Partners held 15,419 shares of Ocular Therapeutix worth $131K as of Q1 2026.
- Ameritas Investment Partners left its Ocular Therapeutix share count unchanged in Q1 2026.
- Ocular Therapeutix made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1526 holding.
- Ameritas Investment Partners first reported a position in Ocular Therapeutix in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Ocular Therapeutix position peaked at $187K in Q4 2025.
- 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.